Bovalto Ibraxion

RSS

Withdrawn

This medicine's authorisation has been withdrawn

infectious bovine rhinotracheitis vaccine (inactivated)
MedicineVeterinaryWithdrawn

Polish is available via eTranslation, the European Commission's machine translation service.

Translate to Polish | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Bovalto Ibraxion has been withdrawn at the request of the marketing authorisation holder.

български (BG) (273.86 KB - PDF)

Zobacz

español (ES) (211.53 KB - PDF)

Zobacz

čeština (CS) (261.66 KB - PDF)

Zobacz

dansk (DA) (213.32 KB - PDF)

Zobacz

Deutsch (DE) (220.08 KB - PDF)

Zobacz

eesti (ET) (204.87 KB - PDF)

Zobacz

ελληνικά (EL) (286.33 KB - PDF)

Zobacz

français (FR) (212.65 KB - PDF)

Zobacz

hrvatski (HR) (231.45 KB - PDF)

Zobacz

italiano (IT) (209.38 KB - PDF)

Zobacz

latviešu (LV) (244.51 KB - PDF)

Zobacz

lietuvių (LT) (233 KB - PDF)

Zobacz

magyar (HU) (249.94 KB - PDF)

Zobacz

Malti (MT) (258.21 KB - PDF)

Zobacz

Nederlands (NL) (211.02 KB - PDF)

Zobacz

polski (PL) (256.51 KB - PDF)

Zobacz

português (PT) (211.11 KB - PDF)

Zobacz

română (RO) (235.21 KB - PDF)

Zobacz

slovenčina (SK) (258.12 KB - PDF)

Zobacz

slovenščina (SL) (244.33 KB - PDF)

Zobacz

suomi (FI) (209.31 KB - PDF)

Zobacz

svenska (SV) (209.74 KB - PDF)

Zobacz

Product information

български (BG) (705.71 KB - PDF)

Zobacz

español (ES) (674.36 KB - PDF)

Zobacz

čeština (CS) (969.79 KB - PDF)

Zobacz

dansk (DA) (624.29 KB - PDF)

Zobacz

Deutsch (DE) (661.81 KB - PDF)

Zobacz

eesti (ET) (692.55 KB - PDF)

Zobacz

ελληνικά (EL) (1.19 MB - PDF)

Zobacz

français (FR) (671.79 KB - PDF)

Zobacz

hrvatski (HR) (767.57 KB - PDF)

Zobacz

italiano (IT) (679.81 KB - PDF)

Zobacz

latviešu (LV) (999.57 KB - PDF)

Zobacz

lietuvių (LT) (791.74 KB - PDF)

Zobacz

magyar (HU) (981.94 KB - PDF)

Zobacz

Malti (MT) (1007.77 KB - PDF)

Zobacz

Nederlands (NL) (671.31 KB - PDF)

Zobacz

polski (PL) (993.05 KB - PDF)

Zobacz

português (PT) (664.06 KB - PDF)

Zobacz

română (RO) (792.26 KB - PDF)

Zobacz

slovenčina (SK) (995.67 KB - PDF)

Zobacz

slovenščina (SL) (960.57 KB - PDF)

Zobacz

suomi (FI) (678.92 KB - PDF)

Zobacz

svenska (SV) (676.34 KB - PDF)

Zobacz

Íslenska (IS) (680.52 KB - PDF)

Zobacz

norsk (NO) (684.14 KB - PDF)

Zobacz
Latest procedure affecting product information:IAIN/0016
10/08/2016

български (BG) (333.69 KB - PDF)

Zobacz

español (ES) (172.7 KB - PDF)

Zobacz

čeština (CS) (205.62 KB - PDF)

Zobacz

dansk (DA) (172.68 KB - PDF)

Zobacz

Deutsch (DE) (173.21 KB - PDF)

Zobacz

eesti (ET) (168.31 KB - PDF)

Zobacz

ελληνικά (EL) (215.76 KB - PDF)

Zobacz

français (FR) (171.23 KB - PDF)

Zobacz

hrvatski (HR) (192.67 KB - PDF)

Zobacz

italiano (IT) (168.65 KB - PDF)

Zobacz

latviešu (LV) (209.34 KB - PDF)

Zobacz

lietuvių (LT) (200.78 KB - PDF)

Zobacz

magyar (HU) (191.94 KB - PDF)

Zobacz

Malti (MT) (214.75 KB - PDF)

Zobacz

Nederlands (NL) (170.59 KB - PDF)

Zobacz

polski (PL) (207.14 KB - PDF)

Zobacz

português (PT) (172.47 KB - PDF)

Zobacz

română (RO) (195.44 KB - PDF)

Zobacz

slovenčina (SK) (209.19 KB - PDF)

Zobacz

slovenščina (SL) (240.02 KB - PDF)

Zobacz

suomi (FI) (166.83 KB - PDF)

Zobacz

svenska (SV) (172.67 KB - PDF)

Zobacz

Íslenska (IS) (170.24 KB - PDF)

Zobacz

norsk (NO) (168.61 KB - PDF)

Zobacz

Product details

Name of medicine
Bovalto Ibraxion
Active substance
inactivated IBR virus
International non-proprietary name (INN) or common name
infectious bovine rhinotracheitis vaccine (inactivated)
Species
Cattle
Anatomical therapeutic chemical veterinary (ATCvet) code
QI02AA03

Pharmacotherapeutic group

Immunologicals for Bovidae

Therapeutic indication

Active immunisation of cattle to reduce the clinical signs of infectious bovine rhinotracheitis (IBR) and field virus excretion.
The onset of immunity is 14 days and the duration of immunity is 6 months.

Authorisation details

EMA product number
EMEA/V/C/000051
Marketing authorisation holder
Merial

29 Avenue Tony Garnier
69007 Lyon
France

Marketing authorisation issued
09/03/2000
Revision
10

Assessment history

This page was last updated on

Share this page